Kavitha Ramachandran
About
In The Last Decade
Kavitha Ramachandran
20 papers receiving 767 citations
Peers
Comparison fields: 5 of 79
- Molecular Biology 627
- Immunology 142
- Cancer Research 133
- Oncology 124
- Pulmonary and Respiratory Medicine 123
Countries citing papers authored by Kavitha Ramachandran
This map shows the geographic impact of Kavitha Ramachandran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kavitha Ramachandran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kavitha Ramachandran more than expected).
Fields of papers citing papers by Kavitha Ramachandran
This network shows the impact of papers produced by Kavitha Ramachandran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kavitha Ramachandran. The network helps show where Kavitha Ramachandran may publish in the future.
Co-authorship network of co-authors of Kavitha Ramachandran
This figure shows the co-authorship network connecting the top 25 collaborators of Kavitha Ramachandran. A scholar is included among the top collaborators of Kavitha Ramachandran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kavitha Ramachandran. Kavitha Ramachandran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 4 | |
| 4 | 5 | |
| 5 | 10 | |
| 6 | 4 | |
| 7 | Role of DNA Methylation in Cabazitaxel Resistance in Prostate Cancer. | 26 |
| 8 | 59 | |
| 9 | 0 | |
| 10 | 5-azacytidine reverses drug resistance in bladder cancer cells. | 21 |
| 11 | 28 | |
| 12 | Methylation-mediated silencing of TMS1 in pancreatic cancer and its potential contribution to chemosensitivity. | 25 |
| 13 | 69 | |
| 14 | Methylation mediated silencing of TMS1 in breast cancer and its potential contribution to docetaxel cytotoxicity. | 16 |
| 15 | The emerging role of epigenetics in urological cancers. | 2 |
| 16 | 17 | |
| 17 | Methylation-mediated silencing of genes is not altered by selenium treatment of prostate cancer cells. | 11 |
| 18 | 91 | |
| 19 | 218 | |
| 20 | 146 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.